# A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

> **NCT02517554** · — · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 120 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Colorectal Cancer

## Interventions

- **BEHAVIORAL:** Penn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site
- **BEHAVIORAL:** Penn genetic counselor provides counseling and test results disclosure by telephone to patient at community site
- **BEHAVIORAL:** Patient receives written information on how to find genetic services in their area

## Key facts

- **NCT ID:** NCT02517554
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2018-03
- **Final completion:** 2019-11
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2024-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02517554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02517554, "A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02517554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*